| scholarly article | Q13442814 |
| P50 | author | Nancy M Dunbar | Q56654720 |
| P2093 | author name string | Xiaotong Wang | |
| Niamh Kieran | |||
| Charles E Alpers | |||
| Kelly D Smith | |||
| Karen Nelson | |||
| Connie Davis | |||
| Jolanta Kowalewska | |||
| Roberto F Nicosia | |||
| Elizabeth Kendrick | |||
| Paul Warner | |||
| Ramaswamy Bakthavatsalam | |||
| James Perkins | |||
| Nicolae Leca | |||
| P2860 | cites work | Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis | Q78571279 |
| Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation | Q79369493 | ||
| C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings | Q80061434 | ||
| Chronic allograft nephropathy | Q80707202 | ||
| Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels | Q81964906 | ||
| Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries | Q31961631 | ||
| Late kidney allograft loss: what we know about it, and what we can do about it | Q35153318 | ||
| Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection | Q36017741 | ||
| Antibody-mediated renal allograft rejection: diagnosis and pathogenesis | Q36759900 | ||
| C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts | Q37042154 | ||
| Transplant glomerulopathy | Q37092282 | ||
| Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys | Q37485481 | ||
| Monoclonal immunoglobulin deposition disease in a renal allograft: probable recurrent disease in a patient without myeloma | Q38224391 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| Clinical significance of allograft glomerulopathy. | Q40782669 | ||
| Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause | Q43580802 | ||
| Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection | Q43747982 | ||
| Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. | Q43830010 | ||
| Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. | Q43931517 | ||
| Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury | Q44512119 | ||
| Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy | Q44695057 | ||
| C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding | Q46539083 | ||
| The UNOS Scientific Renal Transplant Registry--2000. | Q46578429 | ||
| Incidence and importance of c4d deposition in renal allograft dysfunction | Q46763289 | ||
| Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant? | Q46792999 | ||
| Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining | Q46945380 | ||
| Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy | Q47588333 | ||
| Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 | ||
| C4d-positive chronic rejection: a frequent entity with a poor outcome. | Q51722871 | ||
| Transplant glomerulopathy: subclinical incidence and association with alloantibody. | Q53543179 | ||
| Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. | Q53659700 | ||
| Incidence of positive C4d deposition in long-term survival cases over 10 yr after renal transplantation. | Q54106785 | ||
| Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. | Q54380136 | ||
| Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial | Q58378349 | ||
| The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
| Transplant glomerulopathy: evolution of morphologically distinct changes | Q69901036 | ||
| Capillary deposition of C4d complement fragment and early renal graft loss | Q72791721 | ||
| Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts | Q73338525 | ||
| Transplant glomerulopathy as a cause of late graft loss | Q73598692 | ||
| Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection | Q74644326 | ||
| C4d and the fate of organ allografts | Q74644341 | ||
| C4d deposition in acute rejection: an independent long-term prognostic factor | Q77374161 | ||
| P433 | issue | 10 | |
| P921 | main subject | transplant glomerulopathy | Q16258703 |
| P304 | page(s) | 2260-2268 | |
| P577 | publication date | 2009-09-03 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure | |
| P478 | volume | 20 |
| Q38211716 | A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection |
| Q46208009 | Absence of C4d urinary excretion in the early post-transplant period is associated with improved long-term kidney graft survival |
| Q37387510 | Acute transplant glomerulopathy with monocyte rich infiltrate |
| Q92369328 | Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival |
| Q94445562 | Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis |
| Q37058050 | Chronic alloantibody mediated rejection |
| Q37974480 | Clinical role of the renal transplant biopsy |
| Q35001174 | Complement in organ transplantation. |
| Q37014566 | Correlation of histopathologic and dynamic tissue perfusion measurement findings in transplanted kidneys |
| Q42738129 | Dimensions of antibody-mediated rejection |
| Q45966400 | Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. |
| Q53388675 | Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection. |
| Q35124576 | Emerging role of B cells in chronic allograft dysfunction |
| Q64226624 | Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy |
| Q33814904 | Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells |
| Q42223452 | MHC universal cells survive in an allogeneic environment after incompatible transplantation. |
| Q35210278 | Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: results from a multicenter study |
| Q33395896 | Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy |
| Q37058039 | Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts. |
| Q36529421 | Pathological diagnosis of antibody-mediated rejection in renal allograft without c4d staining, how much reliable? |
| Q34423734 | Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation |
| Q53363804 | Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation. |
| Q37127669 | Reuse of a previously transplanted kidney: does success come with a price? |
| Q57474736 | Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection |
| Q51043732 | Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model. |
| Q42598786 | Summary of FDA antibody-mediated rejection workshop |
| Q38676925 | The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations |
| Q37704938 | The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients. |
| Q43805381 | The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome |
| Q54116671 | The prognostic values of caveolin-1 immunoreactivity in peritubular capillaries in patients with kidney transplantation. |
| Q50063069 | Transplant glomerulopathy |
Search more.